HCL Technologies Limited (NSE:HCLTECH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Investors in HCL Technologies Limited (NSE:HCLTECH) had a good week, as its shares rose 2.9% to close at ₹1,496 following the release of its second-quarter results. It was a credible result overall, with revenues of US$3.6b and statutory earnings per share of US$0.18 both in line with analyst estimates, showing that HCL Technologies is executing in line with expectations. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

earnings-and-revenue-growth
NSEI:HCLTECH Earnings and Revenue Growth October 16th 2025

Following the latest results, HCL Technologies' 44 analysts are now forecasting revenues of US$14.6b in 2026. This would be an okay 2.4% improvement in revenue compared to the last 12 months. Statutory per share are forecast to be US$0.73, approximately in line with the last 12 months. In the lead-up to this report, the analysts had been modelling revenues of US$14.4b and earnings per share (EPS) of US$0.73 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

See our latest analysis for HCL Technologies

It will come as no surprise then, to learn that the consensus price target is largely unchanged at ₹1,642. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on HCL Technologies, with the most bullish analyst valuing it at ₹1,980 and the most bearish at ₹1,381 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await HCL Technologies shareholders.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that HCL Technologies' revenue growth is expected to slow, with the forecast 4.8% annualised growth rate until the end of 2026 being well below the historical 7.3% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 6.4% annually. Factoring in the forecast slowdown in growth, it seems obvious that HCL Technologies is also expected to grow slower than other industry participants.

Advertisement

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at ₹1,642, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for HCL Technologies going out to 2028, and you can see them free on our platform here.

It is also worth noting that we have found 1 warning sign for HCL Technologies that you need to take into consideration.

Valuation is complex, but we're here to simplify it.

Discover if HCL Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:HCLTECH

HCL Technologies

Provides IT and business services, engineering, research and development services, software products, and IP-led offerings.

Flawless balance sheet established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1156.8% undervalued
31 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.6% undervalued
47 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
12 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1909.9% undervalued
7 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

ST
StoxEurope
KBC logo
StoxEurope on KBC Group ·

KBC Group (ENXTBR:KBC) Valuation Deep-Dive: Why Dividend and Book Value Models Point in Opposite Directions.

Fair Value:€116.944.9% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FU
A005930 logo
FundamentalFlow on Samsung Electronics ·

Samsung electronics, the DRAM bottleneck, leading the memory shortage wave?

Fair Value:₩500k47.9% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DI
divine_4y1uv
PRG logo
divine_4y1uv on PRG Holdings Berhad ·

Dato’ Ng Yan Cheng Perjelaskan Pendahuluan RM89.55 Juta Bagi Menyokong Kewangan Syarikat

Fair Value:RM 0.361.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75028.2% undervalued
100 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6514.1% undervalued
69 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5449.8% undervalued
64 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative